Global Cytotoxic Drugs Market Size To Exceed USD 27.62 Billion By 2033 | CAGR Of 5.39% [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
USD 27.62 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Pfizer, Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Eli Lilly and Company, Fresenius Kabi AG, Merck & Co., Inc., Amgen Inc., Novartis AG, F. Hoffmann-La Roche Ltd., and Others Key Vendors. New York, United States , April 17, 2024 (GLOBE NEWSWIRE) -- The Global Cytotoxic Drugs Market Size is to Grow from USD 16.34 Billion in 2023 to USD 27.62 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 5.39% during the projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4112 Cytotoxic drugs can be used to remove tumours, enhance surgical or radiation outcomes, reduce metastases, and alleviate cancer symptoms. Cytostatics can be effective outside of the main tumour, eliminating smaller tumours that were not discovered in tests. The need for cytotoxic drugs used in chemotherapy and ta
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer and Genmab's Tivdak wins full FDA approval for cervical cancer [Yahoo! Finance]Yahoo! Finance
- FDA approves Labcorp companion diagnostic for Pfizer gene therapy [Yahoo! Finance]Yahoo! Finance
- 1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation [Yahoo! Finance]Yahoo! Finance
- Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist [Yahoo! Finance]Yahoo! Finance
- Pfizer's ABRYSVO (RSVpreF) for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2023-2032 [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/29/24 - Form 8-K
- 4/26/24 - Form 4
- 4/26/24 - Form 4
- PFE's page on the SEC website